论文信息 - Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer - 字舞流文

Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer

T. Mitsudomi | Y. Sekido | T. Nakagawa | S. Yano | Kunio Matsumoto | S. Takeuchi | Tadaaki Yamada | Takako Sano | S. Nanjo | Daisuke Ishikawa | T. Uenaka | K. Kita | K. Suda | Takahiro J. Nakamura